sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Oligonucleotide Based Therapies Market Scope And Analysis

  • Report Code : TIPRE00022877
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi dell'ambito di mercato e dei concorrenti delle terapie basate sugli oligonucleotidi entro il 2025-2031

Buy Now

Oligonucleotide-based Therapies Market Report Oligonucleotide-based Therapies Market Size and Share Oligonucleotide-based Therapies Market Scope and Analysis

Oligonucleotide-based Therapies Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Tipo
  • Antisenso
  • Ribozimi
  • Aptameri
  • Mirna
  • CPG/Immunostimolante
  • RNAi.
By Applicazione
  • Malattie infettive
  • Oncologia
  • Disturbi neurodegenerativi
  • Malattie cardiovascolari
  • Malattie renali
  • Altro.
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • PCI Biotech
  • SomaGenics
  • InteRNA Technologies
  • Frontiers
  • miRagen Therapeutics, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Aligos Therapeutics
  • Gilead Sciences, Inc.
  • Biogen Inc.